Evaluation of Synthetic Thyrotropin Releasing Hormone (TRH) as a Treatment for Cancer-related Fatigue

Stopped Interim analyses showed statistically and clinically significant results.

Conditions

• Cancer-related Fatigue

Interventions

• DRUG: Thyrotropin releasing hormone (TRH)
• DRUG: Placebo

Sponsor

UConn Health

Collaborators

• [object Object]
• [object Object]